About Us


BMT CTN investigators have published >135 manuscripts, including >30 primary study results papers, in numerous peer-reviewed journals, including the New England Journal of Medicine, Journal of Clinical Oncology, and Blood. Selected publications are summarized for dissemination to patients and the lay public.

Note: Some Publications were unable to be listed below - please see that listing here. All other publications based on PubMedIDs are listed below.


Found 139 results
E. K. Waller, Logan, B. R., Fei, M., Lee, S. J., Confer, D., Howard, A., Chandrakasan, S., Anasetti, C., Fernando, S. M., and Giver, C. R., Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF-mobilized stem cell transplantation., Blood Adv, vol. 3, no. 15, pp. 2250-2263, 2019.
S. A. Holstein, J Ye, C., Howard, A., Bhutani, M., Gormley, N., Hahn, T., Hillengass, J., Krishnan, A., C Landgren, O., Munshi, N. C., Oliva, S., Owen, R. G., Pasquini, M. C., Puig, N., Weinhold, N., Weisel, K., and McCarthy, P. L., Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling., Biol Blood Marrow Transplant, vol. 25, no. 3, pp. e89-e97, 2019.
J. Bolaños-Meade, Reshef, R., Fraser, R., Fei, M., Abhyankar, S., Al-Kadhimi, Z., Alousi, A. M., Antin, J. H., Arai, S., Bickett, K., Bin Chen, Y. -, Damon, L. E., Efebera, Y. A., Geller, N. L., Giralt, S. A., Hari, P., Holtan, S. G., Horowitz, M. M., Jacobsohn, D. A., Jones, R. J., Liesveld, J. L., Logan, B. R., MacMillan, M. L., Mielcarek, M., Noel, P., Pidala, J., Porter, D. L., Pusic, I., Sobecks, R., Solomon, S. R., Weisdorf, D. J., Wu, J., Pasquini, M. C., and Koreth, J., Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with , Lancet Haematol, vol. 6, no. 3, pp. e132-e143, 2019.
S. G. Holtan, DeFor, T. E., Panoskaltsis-Mortari, A., Khera, N., Levine, J. E., Flowers, M. E. D., Lee, S. J., Inamoto, Y., Chen, G. L., Mayer, S., Arora, M., Palmer, J., Cutler, C. S., Arai, S., Lazaryan, A., Newell, L. F., Jagasia, M. H., Pusic, I., Wood, W. A., Renteria, A. S., Yanik, G., Hogan, W. J., Hexner, E., Ayuk, F., Holler, E., Bunworasate, U., Efebera, Y. A., Ferrara, J. L. M., Pidala, J., Howard, A., Wu, J., Bolaños-Meade, J., Ho, V., Alousi, A., Blazar, B. R., Weisdorf, D. J., and MacMillan, M. L., Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802., Blood Adv, vol. 2, no. 15, pp. 1882-1888, 2018.
A. Rashidi, Wangjam, T., Bhatt, A. S., Weisdorf, D. J., and Holtan, S. G., Antibiotic practice patterns in hematopoietic cell transplantation: A survey of blood and marrow transplant clinical trials network centers., Am J Hematol, vol. 93, no. 11, pp. E348-E350, 2018.
A. Rashidi, Shanley, R., Yohe, S. L., Thyagarajan, B., Curtsinger, J., Anasetti, C., Waller, E. K., Miller, J. S., Blazar, B. R., and Weisdorf, D. J., Association between recipient TNF rs361525 and acute GVHD: results from analysis of BMT CTN-0201 samples., Bone Marrow Transplant, vol. 53, no. 8, pp. 1069-1071, 2018.
M. C. Pasquini, Logan, B., Jones, R. J., Alousi, A. M., Appelbaum, F. R., Bolaños-Meade, J., Flowers, M. E. D., Giralt, S., Horowitz, M. M., Jacobsohn, D., Koreth, J., Levine, J. E., Luznik, L., Maziarz, R., Mendizabal, A., Pavletic, S., Perales, M. - A., Porter, D., Reshef, R., Weisdorf, D., and Antin, J. H., Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials., Biol Blood Marrow Transplant, vol. 24, no. 6, pp. 1274-1280, 2018.
S. A. Holstein, Avet-Loiseau, H., Hahn, T., Ho, C. M., Lohr, J. G., Munshi, N. C., Paiva, B., Pasquini, M. C., Tario, J. D., Usmani, S. Z., Wallace, P. K., Weisel, K., and McCarthy, P. L., BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee., Biol Blood Marrow Transplant, vol. 24, no. 4, pp. 641-648, 2018.
L. M. Turcotte, DeFor, T. E., Newell, L. F., Cutler, C. S., Verneris, M. R., Wu, J., Howard, A., MacMillan, M. L., Antin, J. H., Vercellotti, G. M., Slungaard, A., Blazar, B. R., Weisdorf, D. J., Panoskaltsis-Mortari, A., and Holtan, S. G., Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402., Bone Marrow Transplant, vol. 53, no. 1, pp. 64-68, 2018.
R. Spellecy, Tarima, S., Denzen, E., Moore, H., Abhyankar, S., Dawson, P., Foley, A., Gersten, I., Horwitz, M., Idossa, L., Joffe, S., Kamani, N., King, R., Lazaryan, A., Morris, L., Horowitz, M. M., and Majhail, N. S., Easy-to-Read Informed Consent Form for Hematopoietic Cell Transplantation Clinical Trials: Results from the Blood and Marrow Transplant Clinical Trials Network 1205 Study., Biol Blood Marrow Transplant, vol. 24, no. 10, pp. 2145-2151, 2018.
M. J. Martens and Logan, B. R., A group sequential test for treatment effect based on the Fine-Gray model., Biometrics, vol. 74, no. 3, pp. 1006-1013, 2018.
T. M. Andermann, Peled, J. U., Ho, C., Reddy, P., Riches, M., Storb, R., Teshima, T., van den Brink, M. R. M., Alousi, A., Balderman, S., Chiusolo, P., Clark, W. B., Holler, E., Howard, A., Kean, L. S., Koh, A. Y., McCarthy, P. L., McCarty, J. M., Mohty, M., Nakamura, R., Rezvani, K., Segal, B. H., Shaw, B. E., Shpall, E. J., Sung, A. D., Weber, D., Whangbo, J., Wingard, J. R., Wood, W. A., Perales, M. - A., Jenq, R. R., and Bhatt, A. S., The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future., Biol Blood Marrow Transplant, vol. 24, no. 7, pp. 1322-1340, 2018.
P. A. Carpenter, Logan, B. R., Lee, S. J., Weisdorf, D. J., Johnston, L., Costa, L. J., Kitko, C. L., Bolaños-Meade, J., Sarantopoulos, S., Alousi, A. M., Abhyankar, S., Waller, E. K., Mendizabal, A., Zhu, J., O'Brien, K. A., Lazaryan, A., Wu, J., Nemecek, E. R., Pavletic, S. Z., Cutler, C. S., Horowitz, M. M., and Arora, M., A phase II/III randomized, multicenter trial of prednisone/sirolimus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft--host disease: BMT CTN 0801., Haematologica, vol. 103, no. 11, pp. 1915-1924, 2018.
A. Rashidi, Shanley, R., Yohe, S. L., Thyagarajan, B., Curtsinger, J., Anasetti, C., Waller, E. K., Scott, B. L., Blazar, B. R., and Weisdorf, D. J., Recipient single nucleotide polymorphisms in Paneth cell antimicrobial peptide genes and acute graft-versus-host disease: analysis of BMT CTN-0201 and -0901 samples., Br J Haematol, vol. 182, no. 6, pp. 887-894, 2018.
C. E. Allen, Marsh, R., Dawson, P., Bollard, C. M., Shenoy, S., Roehrs, P., Hanna, R., Burroughs, L., Kean, L., Talano, J. - A., Schultz, K. R., Pai, S. - Y., K Baker, S., Andolina, J. R., Stenger, E. O., Connelly, J., Ramirez, A., Bryant, C., Eapen, M., and Pulsipher, M. A., Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies., Blood, vol. 132, no. 13, pp. 1438-1451, 2018.
H. S. L. Jim, Sutton, S., Majhail, N. S., Wood, W. A., Jacobsen, P. B., Wingard, J. R., Wu, J., Knight, J. M., Syrjala, K. L., and Lee, S. J., Severity, course, and predictors of sleep disruption following hematopoietic cell transplantation: a secondary data analysis from the BMT CTN 0902 trial., Bone Marrow Transplant, vol. 53, no. 8, pp. 1038-1043, 2018.
E. P. Smith, Li, H., Friedberg, J. W., Constine, L. S., Rimsza, L. M., Cook, J. R., Laport, G. G., Popplewell, L. L., Holmberg, L. A., Smith, S. M., LeBlanc, M., Forman, S. J., Fisher, R. I., and Stiff, P. J., Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703)., Biol Blood Marrow Transplant, vol. 24, no. 4, pp. 700-707, 2018.
N. Khera, Mau, L. - W., Denzen, E. M., Meyer, C., Houg, K., Lee, S. J., Horowitz, M. M., and Burns, L. J., Translation of Clinical Research into Practice: An Impact Assessment of the Results from the Blood and Marrow Transplant Clinical Trials Network Protocol 0201 on Unrelated Graft Source Utilization., Biol Blood Marrow Transplant, vol. 24, no. 11, pp. 2204-2210, 2018.
K. L. Syrjala, Sutton, S. K., Jim, H. S. L., Knight, J. M., Wood, W. A., Lee, S. J., Jacobsen, P. B., Abidi, M. H., and Yi, J. C., Cancer and treatment distress psychometric evaluation over time: A BMT CTN 0902 secondary analysis., Cancer, vol. 123, no. 8, pp. 1416-1423, 2017.
A. D'Souza, Pasquini, M., Logan, B., Giralt, S., Krishnan, A., Antin, J., Howard, A., Goodman, S., Qazilbash, M., Knust, K., Sahebi, F., Weisdorf, D., Vesole, D., Stadtmauer, E., Maloney, D., and Hari, P., Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study., Br J Haematol, vol. 178, no. 5, pp. 816-819, 2017.
S. G. Holtan, Newell, L. F., Cutler, C., Verneris, M. R., DeFor, T. E., Wu, J., Howard, A., MacMillan, M. L., Antin, J. H., Blazar, B. R., Weisdorf, D. J., and Panoskaltsis-Mortari, A., Low EGF in myeloablative allotransplantation: association with severe acute GvHD in BMT CTN 0402., Bone Marrow Transplant, vol. 52, no. 9, pp. 1300-1303, 2017.
B. L. Scott, Pasquini, M. C., Logan, B. R., Wu, J., Devine, S. M., Porter, D. L., Maziarz, R. T., Warlick, E. D., Fernandez, H. F., Alyea, E. P., Hamadani, M., Bashey, A., Giralt, S., Geller, N. L., Leifer, E., Le-Rademacher, J., Mendizabal, A. M., Horowitz, M. M., H Deeg, J., and Horwitz, M. E., Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes., J Clin Oncol, vol. 35, no. 11, pp. 1154-1161, 2017.
M. Arora, Weisdorf, D. J., Shanley, R. M., and Thyagarajan, B., Pharmacogenetics of steroid-responsive acute graft-versus-host disease., Clin Transplant, vol. 31, no. 5, 2017.
M. Abu Zaid, Wu, J., Wu, C., Logan, B. R., Yu, J., Cutler, C., Antin, J. H., Paczesny, S., and Choi, S. Won, Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT., Blood, vol. 129, no. 2, pp. 162-170, 2017.
J. R. Wingard, Wood, W. A., Martens, M., Le-Rademacher, J., Logan, B., Knight, J. M., Jacobsen, P. B., Jim, H., Majhail, N. S., Syrjala, K., J Rizzo, D., and Lee, S. J., Pretransplantation Exercise and Hematopoietic Cell Transplantation Survival: A Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902)., Biol Blood Marrow Transplant, vol. 23, no. 1, pp. 161-164, 2017.